Accendra Health, Inc.
ACH
$1.12
$0.021.82%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -10.07% | -6.84% | 2.01% | 1.52% | 3.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.07% | -6.84% | 2.01% | 1.52% | 3.26% |
| Cost of Revenue | -2.10% | -1.38% | 6.54% | 5.63% | 3.76% |
| Gross Profit | -18.85% | -12.91% | -2.92% | -2.89% | 2.71% |
| SG&A Expenses | -9.07% | -2.72% | 0.58% | -2.38% | -0.77% |
| Depreciation & Amortization | 288.79% | 292.02% | 320.99% | -- | -25.28% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.59% | 1.56% | 7.42% | 0.81% | 1.33% |
| Operating Income | -119.06% | -113.01% | -61.73% | 10.30% | 36.57% |
| Income Before Tax | -3.15% | -200.96% | 97.36% | -479.44% | -795.90% |
| Income Tax Expenses | 227.95% | -515.74% | -95.06% | 750.83% | 58.87% |
| Earnings from Continuing Operations | -6.26% | -69.76% | 97.15% | -544.65% | -1,143.28% |
| Earnings from Discontinued Operations | -- | -- | -231.16% | -931.07% | -3,019.61% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 89.75% | 74.11% | 80.98% | -1,076.79% | -2,623.21% |
| EBIT | -119.06% | -113.01% | -61.73% | 10.30% | 36.57% |
| EBITDA | -38.93% | -40.08% | 40.35% | 6.88% | -7.72% |
| EPS Basic | 89.72% | 73.83% | 80.96% | -1,073.45% | -2,616.04% |
| Normalized Basic EPS | -1,220.99% | -266.02% | -122.75% | 24.88% | -58.78% |
| EPS Diluted | 89.72% | 73.89% | 80.83% | -1,073.45% | -2,601.87% |
| Normalized Diluted EPS | -1,220.99% | -266.02% | -122.75% | 27.13% | -58.78% |
| Average Basic Shares Outstanding | -0.31% | -1.09% | -0.05% | 0.26% | 0.27% |
| Average Diluted Shares Outstanding | -0.31% | -1.09% | -0.05% | -1.51% | 0.27% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |